Skip to main content
Log in

Remnant Liver Tumor Growth Activity During Treatment Associating Liver Partition and Portal Vein Occlusion for Staged Hepatectomy (ALPPS)

  • Original Article
  • Published:
Journal of Gastrointestinal Surgery Aims and scope

Abstract

Background

We compared tumor growth activity during treatment associating liver partition and portal vein occlusion for staged hepatectomy (ALPPS) with that in classical 2-stage hepatectomy.

Methods

Short-term outcomes, serial changes in volume of the future liver remnant (FLR), and tumor growth activity during the treatment period were compared between 12 patients treated with ALPPS and 20 patients treated with 2-stage hepatectomy for colorectal liver metastases. This study was registered in UMIN Clinical Trials Registry (registration number, UMIN000018622).

Results

The FLR hypertrophy ratio at 1 week after the first operation was greater in the ALPPS group (1.43 ± 0.24) than the 2-stage group (1.21 ± 0.28, P = 0.043). The mean kinetic growth rate (mKGR) of tumors in the ALPPS group (0.548 ± 7.29 mL/day) did not differ significantly from that in the 2-stage group (−3.53 ± 7.02 mL/day) in the first week after the initial procedure (P = 0.210). However, mKGR between 1 and 3 weeks after the first procedure (1.29 ± 2.34 mL/day) was significantly greater than that in first week after the procedure in the 2-stage group (P = 0.034).

Conclusions

ALPPS induces a rapid FLR volume increase while avoiding remnant tumor progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Adam R, Lauren A, Azoulay D, Castaing D, Bismuth H. Two-stage Hepatectomy: A Planned Strategy to Treat Irresectable Liver Tumors. Ann Surg 2000;232:777–785.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Kokudo N, Tada K, Seki M, Ohta H, Azekura K, Ueno M, Ohta K, Yamaguchi T, Matsubara T, Takahashi T, Nakajima T, Muto T, Ikari T, Yanagisawa A, Kato Y. Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology 2001;34:267–272.

    Article  CAS  PubMed  Google Scholar 

  3. Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, Fichtner-Feigl S, Lorf T, Goralcyk A, Hörbelt R, Kroemer A, Loss M, Rümmele P, Scherer MN, Padberg W, Königsrainer A, Lang H, Obed A, Schlitt HJ. Right Portal Vein Ligation Combined With In Situ Splitting Induces Rapid Left Lateral Liver Lobe Hypertrophy Enabling 2-Staged Extended Right Hepatic Resection in Small-for-Size Settings. Ann Surg 2012;255:405–414.

    Article  PubMed  Google Scholar 

  4. Santiba E, Alvarez FA, Ardiles V. How to Avoid Postoperative Liver Failure: A Novel Method. World J Surg 2012;36:125–128.

    Article  Google Scholar 

  5. Alvarez FA, Iniesta J, Lastiri J, Ulla M, Bonadeo Lassalle F, de Santibañes E. New Method of Hepatic Regeneration. Cir Esp 2011;89:645–649.

    Article  PubMed  Google Scholar 

  6. Tanaka K, Matsuo K, Murakami T, Kawaguchi D, Hiroshima Y, Koda K, Endo I, Ichikawa Y, Taguri M, Tanabe M. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): short-term outcome, functional changes in the future liver remnant, and tumor growth activity. Eur J Surg Oncol 2015;41:506–512.

    Article  CAS  PubMed  Google Scholar 

  7. de Santibañes E, Clavien PA. Playing Play-Doh to prevent postoperative liver failure: the "ALPPS" approach. Ann Surg 2012;255:415–417.

    Article  PubMed  Google Scholar 

  8. Yamanaka N, Okamoto E, Oriyama T, Fujimoto J, Furukawa K, Kawamura E, Tanaka T, Tomoda F. A prediction scoring system to select the surgical treatment of liver cancer. Further refinement based on 10 years of use. Ann Surg. 1994;219:342–346.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Tanaka K, Kikuchi Y, Kawaguchi D, Murakami T, Hiroshima Y, Matsuo K. Modified ALPPS Procedures Avoiding Division of Portal Pedicles. Ann Surg 2017;265:14–20.

    Article  Google Scholar 

  10. Terminology Committee of the International Hepato-Pancreato-Biliary Association. The Brisbane 2000 Terminology of Liver Anatomy and Resection. HPB 2000;2:333–339.

    Article  Google Scholar 

  11. Croome KP, Hernandez-Alejandro R, Parker M, Heimbach J, Rosen C, Nagorney DM. Is the liver kinetic growth rate in ALPPS unprecedented when compared with PVE and living donor liver transplant? A multicentre analysis. HPB 2015;17:477–484.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Dindo D, Demartines N, Clavien PA. Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey. Ann Surg 2004;240:205–213.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R, Koch M, Makuuchi M, Dematteo RP, Christophi C, Banting S, Usatoff V, Nagino M, Maddern G, Hugh TJ, Vauthey JN, Greig P, Rees M, Yokoyama Y, Fan ST, Nimura Y, Figueras J, Capussotti L, Büchler MW, Weitz J. Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 2011;149:713–724.

    Article  PubMed  Google Scholar 

  14. Shindoh J, Vauthey J, Zimmitti G, Curley SA, Huang SY, Mahvash A, Gupta S, Wallace MJ, Aloia TA. Analysis of the Efficacy of Portal Vein Embolization for Patients with Extensive Liver Malignancy and Very Low Future Liver Remnant Volume, Including a Comparison with the Associating Liver Partition with Portal Vein Ligation for Staged Hepatectomy Approach. J Am Coll Surg 2013;217:126–133.

    Article  PubMed  Google Scholar 

  15. Jiang W, Hiscox S, Matsumoto K, Nakamura T. Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer. Crit Rev Oncol Hematol 1999;29:209–248.

    Article  CAS  PubMed  Google Scholar 

  16. Lukomska B, Dluzniewska J, Polanski J, Zajac L. Expression of growth factors in colorectal carcinoma liver metastatic patients after partial hepatectomy: implications for a functional role in cell proliferation during liver regeneration. Comp Hepatol 2004;3:S52.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Yoon SS, Kim SH, Gonen M, Heffernan NM, Detwiller KY, Jarnagin WR, D'Angelica M, Blumgart LH, Tanabe KK, Dematteo RP. Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases. Ann Surg Oncol 2006;13:353–362.

    Article  PubMed  Google Scholar 

  18. Aloia TA, Vauthey JN. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): what is gained and what is lost? Ann Surg 2012;256:e9.

    Article  PubMed  Google Scholar 

  19. Graaf W, Esschert JW, Lienden KP, van Gulik TM. Induction of Tumor Growth After Preoperative Portal Vein Embolization: Is it a Real Problem? Ann Surg Oncol 2009;16:423–430.

    Article  PubMed  Google Scholar 

  20. Hoekstra L, Lienden K, Verheij J, van der Loos CM, Heger M, van Gulik TM. Enhanced tumor growth after portal vein embolization in a rabbit tumor model. J Surg Res 2013;180:89–96.

    Article  PubMed  Google Scholar 

  21. Oldhafer KJ, Donati M, Jenner RM, Stang A, Stavrou GA. ALPPS for Patients With Colorectal Liver Metastases: Effective Liver Hypertrophy, but Early Tumor Recurrence. World J Surg 2014;38:1504–1509.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Yutaro Kikuchi: meet all 4 criteria of guidelines of ICMJE, Yukihiko Hiroshima; meet all 4 criteria of guidelines of ICMJE, Kenichi Matsuo; meet all 4 criteria of guidelines of ICMJE, Takashi Murakami; meet all 4 criteria of guidelines of ICMJE, Daisuke Kawaguchi; meet all 4 criteria of guidelines of ICMJE, Kazuto Yamazaki; meet all 4 criteria of guidelines of ICMJE, Yasuo Ishida; meet all 4 criteria of guidelines of ICMJE, Itaru Endo; meet all 4 criteria of guidelines of ICMJE, Kuniya Tanaka; meet all 4 criteria of guidelines of ICMJE.

Corresponding author

Correspondence to Kuniya Tanaka.

Ethics declarations

Grant support for the research reported

There were no grant support about our study.

Conflict of Interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kikuchi, Y., Hiroshima, Y., Matsuo, K. et al. Remnant Liver Tumor Growth Activity During Treatment Associating Liver Partition and Portal Vein Occlusion for Staged Hepatectomy (ALPPS). J Gastrointest Surg 21, 1851–1858 (2017). https://doi.org/10.1007/s11605-017-3523-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-017-3523-x

Keywords

Navigation